According to the research report titled ‘North America Rare Sugar Market Forecast 2026 by Product, Application, Research Report, COVID-19 Impact Statistics, Country Outlook, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share’, available with Market Study Report, North America rare sugar market is expected to record a notable CAGR over 2015-2026.
 

Rising preference for natural low-calorie sweeteners for prevention of conditions such as diabetes is one of the major factors stimulating North America rare sugar industry growth. Additionally, increasing health consciousness, and growing consumer inclination towards ‘natural’ products are expected to favor industry development in the upcoming years.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3963047/
 

For the unversed, rare sugars contain lesser calories as compared to common sugars like sucrose, fructose, and lactose. These sugars are available in limited quantities in nature and are classified into over fifty different types.
 

Based on product type, the industry classification comprises D-mannose, tagatose, allulose, L-arabinose, D-xylose, and L-fucose. In 2019, revenue from the D-mannose segment was USD 300 million. D-mannose is vital for metabolism and can be used to treat glycoprotein syndrome and urinary tract infections. Meanwhile, the allulose segment was worth USD 15 million in 2019, driven by its extensive use as a low-calorie sweetener.
 

Moving on to application ambit, North America rare sugar industry is arrayed into dietary supplements, pharmaceuticals, cosmetics & personal care, food & beverages, and others. Among these, dietary supplements sector generated USD 185 million in 2019, owing to increasing product demand in order to meet daily nutritional needs and to improve skin & bone health.
 

Considering the regional outlook, Canada industry is touted to register remarkable growth over the forecast period, due to rising rates of obesity and diabetes in the region. Notably, the number of people suffering from type 2 diabetes in Canada is expected to increase from 3.5 million in 2015 to 5 million by 2025. Such drastic rise in diabetics is expected to boost the regional market outlook through 2026.
 

Major contenders in North America rare sugar marketplace are Sweet Cures Ltd., Ingredion Inc., Bonumose Inc., Matsutani Chemical Industry Co. Ltd., Samyang Corp., Nutraceuticals Group USA, DuPont de Nemours Inc., Sanwa Starch Co. Ltd., Tate & Lyle plc, and Douglas Laboratories.